Structure and Pharmacophore Elucidation of the HRV143C Protease Trent Bjorndahl Faculty of Pharmacy - PowerPoint PPT Presentation

1 / 21
About This Presentation
Title:

Structure and Pharmacophore Elucidation of the HRV143C Protease Trent Bjorndahl Faculty of Pharmacy

Description:

Structure and Pharmacophore Elucidation of the HRV14-3C Protease. Trent Bjorndahl ... 1Rates of peptide hydrolysis are expressed relative to 2C-3A and are the mean of ... – PowerPoint PPT presentation

Number of Views:97
Avg rating:3.0/5.0
Slides: 22
Provided by: tre51
Category:

less

Transcript and Presenter's Notes

Title: Structure and Pharmacophore Elucidation of the HRV143C Protease Trent Bjorndahl Faculty of Pharmacy


1
Structure and Pharmacophore Elucidation of the
HRV14-3C ProteaseTrent
BjorndahlFaculty of Pharmacy and Pharmaceutical
SciencesOct. 9, 2003
2
Background
  • Rhinovirus
  • More 110 known serotypes
  • polyvalent vaccine vs. Small molecule inhibitors
  • 3C Protease

3
Picornovirii Life Cycle
4
Picornovirii Gene Products
  • 3C Protease
  • Lytic Activity
  • RNA Binding
  • Down Regulation
  • NOT HAV

5
HRV14-3C Specificity
1Rates of peptide hydrolysis are expressed
relative to 2C-3A and are the mean of two or more
independent determinations.
  • Cordingley, M. G. et al., Cleavage of Small
    Peptides In Vitro by Human Rhinovirus 14 3C
    Protease Expressed in Escherichia coli. J.
    Virol., 1989, 63 5037-5045.

6
3C Protease Backbone Dynamics
7
Project
  • Determine solution structures of free and
    peptidyl-inhibited HRV14-3C
  • Model other enzyme-substrate complexes
  • Analyze HRV14-3C pharmacophore

8
Expression, Purification and Sample Conditions
OD600 0.8 30 Celsius 0.2 IPTG 12 - 14 hours
9
Expression, Purification and Sample Conditions
  • Q Sepharose
  • Tris-HCl pH 8.8 - 9.2
  • 2.5 - 5 ml/min.
  • 4 Celsius

10
Expression, Purification and Sample Conditions
Button test Ultracentrifugation monomer/dimer
24kDa 1mM HRV14-3C, 20mM KH2PO4, pH 6.5, 15mM
DTT, 0.5mM EDTA
11
Synthesis of a peptidyl inhibitor
Modified 2C/3A cleavage site
12
(No Transcript)
13
Inhibitor analysis
ES-MS MALDI-TOF within 5amu
14
Inhibitor analysis
15
NMR experiments
Backbone experiments - sequential
assignment HNCA HNCACB CBCACONH HNHA NOESY-HSQC
16
NMR experiments
V47 strips ? and amide protons A. 13C
NOESY-HSQC B. 13C HCCH-TOCSY C. 15N NOESY-HSQC D.
15N TOCSY-HSQC
17
Structure Determination
18
Preliminary analysis
19
Preliminary Analysis
20
Future work
  • Complete the two structures
  • uninhibited 1700 NOES 1.8A
  • D2O NOESY TOCSY data
  • N Q side chains
  • inhibited backbone assignments
  • Pharmacophore analysis

21
Thank You
  • Inhibitor synthesis
  • Lena Andrew
  • Dr. Raj Jain
  • Carlos Velazquez
  • Praveen Rao
  • NMR
  • Hassan Monzavi
  • Dr. Ryan McKay
  • Dr. Pascal Mercier
Write a Comment
User Comments (0)
About PowerShow.com